Mingfei Yan
- Complementary and Manual Therapy top 10%
- Aquatic Science top 10%
-
- Cancer and Skin Lesions 4
- Cutaneous lymphoproliferative disorders research 2
-
- Chronic Lymphocytic Leukemia Research 4
-
- Lymphoma Diagnosis and Treatment 4
-
- CNS Lymphoma Diagnosis and Treatment 2
-
- PI3K/AKT/mTOR signaling in cancer 2
- Protein Kinase Regulation and GTPase Signaling 2
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Weidong ChengDongfeng WeiWanghong ZhaoTong ChenLixia YuanFei LiAndrew M. ChanAparna Harbhajanka
- Partner nations
- United StatesHong KongChina
In The Last Decade
Mingfei Yan
22 papers receiving 363 citations
Peers
Comparison fields: 5 of 79
- Complementary and Manual Therapy 12
- Nutrition and Dietetics 79
- Aquatic Science 31
- Molecular Medicine 16
- Dermatology 26
Countries citing papers authored by Mingfei Yan
This map shows the geographic impact of Mingfei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfei Yan more than expected).
Fields of papers citing papers by Mingfei Yan
This network shows the impact of papers produced by Mingfei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfei Yan. The network helps show where Mingfei Yan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mingfei Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 10 | |
| 7 | 2021 | 0 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 2 | |
| 10 | 2020 | 1 | |
| 11 | 2020 | 1 | |
| 12 | 2018 | 20 | |
| 13 | 2018 | 6 | |
| 14 | 2018 | 16 | |
| 15 | 2017 | 10 | |
| 16 | 2017 | 29 | |
| 17 | 2015 | 3 | |
| 18 | 2015 | 7 | |
| 19 | 2012 | 10 | |
| 20 | 2011 | 2 |
About Mingfei Yan
Mingfei Yan is a scholar working on Dermatology, Genetics, Pathology and Forensic Medicine, Immunology and Allergy and Oncology, having authored 26 papers that have together received 366 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), Cancer and Skin Lesions (4 papers), Lymphoma Diagnosis and Treatment (4 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cutaneous lymphoproliferative disorders research (2 papers). The work is most often cited by research in Complementary and Manual Therapy (12 citations), Nutrition and Dietetics (79 citations), Aquatic Science (31 citations), Molecular Medicine (16 citations) and Dermatology (26 citations). Mingfei Yan has collaborated with scholars based in United States, Hong Kong and China. Frequent co-authors include Weidong Cheng, Dongfeng Wei, Wanghong Zhao, Tong Chen, Lixia Yuan, Fei Li, Andrew M. Chan, Aparna Harbhajanka, Hannah Gilmore and Yubing Wang. Their work appears in journals such as Cancer Letters, Autism Research, Virology Journal, Journal of Clinical Microbiology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.